GPCM
MRNS
Granite Point Capital Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-472,056
| Closed | -$3.14M | – | 113 |
|
|
2022
Q3 | $3.14M | Hold |
472,056
| – | – | 1.27% | 7 |
|
|
2022
Q2 | $2.29M | Hold |
472,056
| – | – | 0.58% | 13 |
|
|
2022
Q1 | $4.41M | Buy |
472,056
+52,732
| +13% | +$493K | 0.92% | 13 |
|
|
2021
Q4 | $4.98M | Hold |
419,324
| – | – | 0.84% | 12 |
|
|
2021
Q3 | $4.77M | Hold |
419,324
| – | – | 0.37% | 13 |
|
|
2021
Q2 | $7.52M | Sell |
419,324
-50,000
| -11% | -$897K | 0.28% | 5 |
|
|
2021
Q1 | $7.27M | Sell |
469,324
-50
| -0% | -$774 | 0.27% | 7 |
|
|
2020
Q4 | $5.73M | Hold |
469,374
| – | – | 0.29% | 11 |
|
|
2020
Q3 | $6.03M | Sell |
469,374
-1,783,744
| -79% | -$22.9M | 0.33% | 8 |
|
|
2020
Q2 | $5.72M | Buy |
2,253,118
+364,018
| +19% | +$925K | 0.29% | 9 |
|
|
2020
Q1 | $3.84M | Sell |
1,889,100
-810,900
| -30% | -$1.65M | 2.17% | 9 |
|
|
2019
Q4 | $5.83M | Sell |
2,700,000
-840,819
| -24% | -$1.82M | 0.91% | 3 |
|
|
2019
Q3 | $5.45M | Buy |
3,540,819
+200,000
| +6% | +$308K | 0.85% | 2 |
|
|
2019
Q2 | $13.9M | Buy |
3,340,819
+295,412
| +10% | +$1.23M | 0.93% | 1 |
|
|
2019
Q1 | $12.7M | Buy |
3,045,407
+386,040
| +15% | +$1.61M | 1.23% | 1 |
|
|
2018
Q4 | $7.63M | Buy |
2,659,367
+1,600,000
| +151% | +$4.59M | 1.54% | 1 |
|
|
2018
Q3 | $10.6M | Sell |
1,059,367
-1,578,954
| -60% | -$15.8M | 0.7% | 1 |
|
|
2018
Q2 | $18.7M | Hold |
2,638,321
| – | – | 1.67% | 1 |
|
|
2018
Q1 | $10.1M | Buy |
2,638,321
+359,473
| +16% | +$1.37M | 0.97% | 1 |
|
|
2017
Q4 | $18.6M | Sell |
2,278,848
-406,000
| -15% | -$3.31M | 1.82% | 1 |
|
|
2017
Q3 | $15.8M | Buy |
2,684,848
+1,918,400
| +250% | +$11.3M | 3.32% | 1 |
|
|
2017
Q2 | $1.05M | Sell |
766,448
-8,552
| -1% | -$11.7K | 0.26% | 53 |
|
|
2017
Q1 | $1.37M | Buy |
+775,000
| New | +$1.37M | 0.41% | 30 |
|